PorMedTec
PorMedTec is a company dedicated to advancing xenotransplantation and regenerative medicine using genetically engineered pigs. Established in 2017, it aims to address the critical shortage of human organ donors by producing medical-grade, pathogen-free pigs for organ transplantation. The company leverages cutting-edge genetic modification and cloning technologies to develop transplantable organs, tissues, and cells, contributing to global medical care and human health.
Industries
Nr. of Employees
small (1-50)
PorMedTec
Meiji University Center of Collaborative Innovation and Incubation, T201, 2-3227 Mita, Tama, Kawasaki 214-0034, Japan
Patents
Disease model pig exhibiting stable phenotype, and production method thereof
US-11246299-B2
View Details
Disease model pig exhibiting stable phenotype, and production method thereof
US-11246299-B2
View DetailsProducts
Pancreatic islets for xenotransplantation
Production and sale of pancreatic islets derived from genetically engineered pigs intended for xenotransplantation research and application.
Humanized organs for transplantation
Development and production of organs with humanized characteristics using genetically engineered DPF pigs and pluripotent stem cell–based approaches for potential transplant use.
Genetically engineered pig organs for xenotransplantation
Production and commercialization of organs from genetically modified pigs designed for compatibility with human recipients and for use in clinical xenotransplantation development.
Pancreatic islets for xenotransplantation
Production and sale of pancreatic islets derived from genetically engineered pigs intended for xenotransplantation research and application.
Humanized organs for transplantation
Development and production of organs with humanized characteristics using genetically engineered DPF pigs and pluripotent stem cell–based approaches for potential transplant use.
Genetically engineered pig organs for xenotransplantation
Production and commercialization of organs from genetically modified pigs designed for compatibility with human recipients and for use in clinical xenotransplantation development.
Services
Contract creation and cloning of genetically engineered pigs tailored to client specifications for use in organ-regeneration research, preclinical validation, and xenotransplantation development.
Consulting to develop optimized vitrification/cryopreservation protocols for biological materials such as embryos, pancreatic islets, organoids, and cell sheets.
Contract creation and cloning of genetically engineered pigs tailored to client specifications for use in organ-regeneration research, preclinical validation, and xenotransplantation development.
Consulting to develop optimized vitrification/cryopreservation protocols for biological materials such as embryos, pancreatic islets, organoids, and cell sheets.
Expertise Areas
- Xenotransplantation
- Genetic engineering and cloning of large animals
- Designated pathogen-free (DPF) animal production
- Cryopreservation and vitrification techniques
Key Technologies
- Somatic cell nuclear transfer (cloning)
- Genome editing of porcine cells
- In vitro oocyte maturation and fertilization
- ICSI-mediated gene transfer
News & Updates
Science magazine Newton features the company's efforts.
NHK Special 'Human Body III' features xenotransplantation.
Nikkei Medical introduces the company's initiatives.
CNN reports on pig kidney transplantation.
Asahi reports on xenotransplantation clinical trials in the US.
Brazilian TV Fala Brasil features the company's efforts.
Science magazine Newton features the company's efforts.
NHK Special 'Human Body III' features xenotransplantation.
Nikkei Medical introduces the company's initiatives.
CNN reports on pig kidney transplantation.
Asahi reports on xenotransplantation clinical trials in the US.
Brazilian TV Fala Brasil features the company's efforts.